Alesta Therapeutics is a biotech company focused on development of innovative therapies targeting synthetic lethal metabolic dependencies in cancer. Alesta has established a pipeline of first-in-class small molecule programs. Its lead program targets a control mechanism involved in the stress response pathways required for cancer cell survival.